Figure 2 | Modern Pathology

Figure 2

From: Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions

Figure 2

(a) Association between MAP3K7 deletion and biochemical recurrence in prostate cancer. (b)Association of MAP3K7 deletion status to ERG fusion status (P<0001). Association between MAP3K7 deletion in ERG fusion-negative (c) and -positive (d) tumors and biochemical recurrence in prostate cancer. Normal: two MAP3K7 gene copies, Heterozygous: heterozygous deletion with one MAP3K7 gene copy.

Back to article page